0 XP   0   0   0

VISTA PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Should you buy, hold or sell VISTA PHARMACEUTICALS LTD.?

I guess you are interested in VISTA PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse VISTA PHARMACEUTICALS LTD.

Let's start. I'm going to help you getting a better view of VISTA PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is VISTA PHARMACEUTICALS LTD. even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how VISTA PHARMACEUTICALS LTD. is doing in the market. If the company is worth buying. The latest step is to find out how other investors value VISTA PHARMACEUTICALS LTD.. The closing price on 2023-01-25 was INR10.65 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
VISTA PHARMACEUTICALS LTD. Daily Candlestick Chart
VISTA PHARMACEUTICALS LTD. Daily Candlestick Chart
Summary









1. Valuation of VISTA PHARMACEUTICALS LTD.




Current price per share

INR10.65

2. Growth of VISTA PHARMACEUTICALS LTD.




Is VISTA PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$4.3m$4m$320.6k7.4%

How much money is VISTA PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money-$102.3k-$231.8k$129.5k126.6%
Net Profit Margin-210.8%-148.9%--

How much money comes from the company's main activities?

3. Financial Health of VISTA PHARMACEUTICALS LTD.




Comparing to competitors in the Drug Manufacturers-Specialty & Generic industry




  Industry Rankings (Drug Manufacturers-Specialty & Generic)  


Richest
#395 / 705

Most Revenue
#565 / 705

Most Profit
#509 / 705

Most Efficient
#597 / 705


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of VISTA PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit VISTA PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -210.8% means that ₹-2.11 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -210.8%. The company is making a huge loss. -2
  • The TTM is -210.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-210.8%TTM-210.8%0.0%
TTM-210.8%YOY-148.9%-62.0%
TTM-210.8%5Y-73.1%-137.8%
5Y-73.1%10Y-33.9%-39.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-210.8%0.4%-211.2%
TTM-210.8%0.3%-211.1%
YOY-148.9%0.2%-149.1%
5Y-73.1%-0.7%-72.4%
10Y-33.9%-0.1%-33.8%
1.1.2. Return on Assets

Shows how efficient VISTA PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • -1.5% Return on Assets means that VISTA PHARMACEUTICALS LTD. generated ₹-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -1.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM-1.5%0.0%
TTM-1.5%YOY-3.7%+2.2%
TTM-1.5%5Y-1.3%-0.2%
5Y-1.3%10Y0.9%-2.2%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%0.1%-1.6%
TTM-1.5%0.1%-1.6%
YOY-3.7%-0.1%-3.6%
5Y-1.3%-0.2%-1.1%
10Y0.9%0.1%+0.8%
1.1.3. Return on Equity

Shows how efficient VISTA PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • -2.3% Return on Equity means VISTA PHARMACEUTICALS LTD. generated ₹-0.02 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2.3%0.0%
TTM-2.3%YOY-5.7%+3.4%
TTM-2.3%5Y-2.2%-0.1%
5Y-2.2%10Y2.1%-4.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%0.6%-2.9%
TTM-2.3%0.4%-2.7%
YOY-5.7%0.4%-6.1%
5Y-2.2%-0.3%-1.9%
10Y2.1%0.1%+2.0%

1.2. Operating Efficiency of VISTA PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient VISTA PHARMACEUTICALS LTD. is operating .

  • Measures how much profit VISTA PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.0%+0.0%
5Y0.0%10Y4.3%-4.3%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.5%-2.5%
TTM-1.6%-1.6%
YOY-2.7%-2.7%
5Y0.0%1.8%-1.8%
10Y4.3%0.8%+3.5%
1.2.2. Operating Ratio

Measures how efficient VISTA PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 6.64 means that the operating costs are ₹6.64 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 6.636. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.636. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.636TTM6.6360.000
TTM6.636YOY3.550+3.086
TTM6.6365Y3.130+3.506
5Y3.13010Y2.370+0.760
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6361.473+5.163
TTM6.6361.456+5.180
YOY3.5501.398+2.152
5Y3.1301.374+1.756
10Y2.3701.191+1.179

1.3. Liquidity of VISTA PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if VISTA PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 1.43 means the company has ₹1.43 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 1.434. The company is just able to pay all its short-term debts.
  • The TTM is 1.434. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.434TTM1.4340.000
TTM1.434YOY1.648-0.214
TTM1.4345Y1.677-0.243
5Y1.67710Y1.380+0.297
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4341.880-0.446
TTM1.4341.901-0.467
YOY1.6482.112-0.464
5Y1.6772.182-0.505
10Y1.3801.891-0.511
1.3.2. Quick Ratio

Measures if VISTA PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Quick Ratio of 0.24 means the company can pay off ₹0.24 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.240. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.240. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.240TTM0.2400.000
TTM0.240YOY0.235+0.006
TTM0.2405Y0.572-0.332
5Y0.57210Y0.613-0.041
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2400.733-0.493
TTM0.2400.796-0.556
YOY0.2350.808-0.573
5Y0.5720.834-0.262
10Y0.6130.821-0.208

1.4. Solvency of VISTA PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of VISTA PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.36 means that VISTA PHARMACEUTICALS LTD. assets are financed with 36.2% credit (debt) and the remaining percentage (100% - 36.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.362. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.362. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.362TTM0.3620.000
TTM0.362YOY0.354+0.008
TTM0.3625Y0.371-0.009
5Y0.37110Y0.434-0.062
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3620.437-0.075
TTM0.3620.424-0.062
YOY0.3540.398-0.044
5Y0.3710.398-0.027
10Y0.4340.401+0.033
1.4.2. Debt to Equity Ratio

Measures if VISTA PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Debt to Equity ratio of 56.8% means that company has ₹0.57 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.568. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.568. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.568TTM0.5680.000
TTM0.568YOY0.548+0.020
TTM0.5685Y0.596-0.028
5Y0.59610Y0.762-0.166
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5680.652-0.084
TTM0.5680.675-0.107
YOY0.5480.623-0.075
5Y0.5960.684-0.088
10Y0.7620.697+0.065

2. Market Valuation of VISTA PHARMACEUTICALS LTD.

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings VISTA PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare VISTA PHARMACEUTICALS LTD. to the Drug Manufacturers-Specialty & Generic industry mean.
  • A PE ratio of -40.78 means the investor is paying ₹-40.78 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The EOD is -47.104. Company is losing money. -2
  • The MRQ is -40.779. Company is losing money. -2
  • The TTM is -40.779. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-47.104MRQ-40.779-6.325
MRQ-40.779TTM-40.7790.000
TTM-40.779YOY-17.644-23.135
TTM-40.7795Y15.078-55.857
5Y15.07810Y47.035-31.958
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-47.104-0.124-46.980
MRQ-40.779-0.437-40.342
TTM-40.779-0.102-40.677
YOY-17.64415.340-32.984
5Y15.0787.916+7.162
10Y47.0357.700+39.335
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of VISTA PHARMACEUTICALS LTD..

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -26.162. Very Bad. -2
  • The TTM is -26.162. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-26.162TTM-26.1620.000
TTM-26.162YOY-11.863-14.299
TTM-26.1625Y35.723-61.885
5Y35.72310Y43.505-7.782
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.1620.012-26.174
TTM-26.1620.010-26.172
YOY-11.8630.004-11.867
5Y35.7230.010+35.713
10Y43.5050.021+43.484

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of VISTA PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.96 means the investor is paying ₹0.96 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The EOD is 1.105. Good. +1
  • The MRQ is 0.957. Very good. +2
  • The TTM is 0.957. Very good. +2
Trends
Current periodCompared to+/- 
EOD1.105MRQ0.957+0.148
MRQ0.957TTM0.9570.000
TTM0.957YOY1.013-0.056
TTM0.9575Y1.779-0.822
5Y1.77910Y3.101-1.321
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD1.1051.415-0.310
MRQ0.9571.586-0.629
TTM0.9572.019-1.062
YOY1.0132.230-1.217
5Y1.7791.895-0.116
10Y3.1011.505+1.596
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of VISTA PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7090.7090%0.871-19%1.050-33%0.964-26%
Book Value Growth--1.0791.0790%1.108-3%1.223-12%1.204-10%
Book Value Per Share--9.6369.6360%8.927+8%9.001+7%6.009+60%
Book Value Per Share Growth--1.0791.0790%1.108-3%1.223-12%1.204-10%
Current Ratio--1.4341.4340%1.648-13%1.677-14%1.380+4%
Debt To Asset Ratio--0.3620.3620%0.354+2%0.371-2%0.434-17%
Debt To Equity Ratio--0.5680.5680%0.548+4%0.596-5%0.762-25%
Dividend Per Share----0%-0%-0%-0%
Eps---0.226-0.2260%-0.512+127%-0.178-21%0.019-1320%
Eps Growth--1.5591.5590%1.487+5%0.263+493%1.231+27%
Free Cash Flow Per Share---0.274-0.2740%-1.915+599%-1.445+428%-0.902+230%
Free Cash Flow Per Share Growth--1.8571.8570%-5.634+403%-12.462+771%-10.124+645%
Free Cash Flow To Equity Per Share---0.274-0.2740%-1.915+599%-0.757+177%-0.207-25%
Free Cash Flow To Equity Per Share Growth--1.8571.8570%-5.634+403%-0.333+118%8.650-79%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---6.726--------
Intrinsic Value_10Y_min---5.635--------
Intrinsic Value_1Y_max---0.361--------
Intrinsic Value_1Y_min---0.351--------
Intrinsic Value_3Y_max---1.323--------
Intrinsic Value_3Y_min---1.245--------
Intrinsic Value_5Y_max---2.573--------
Intrinsic Value_5Y_min---2.343--------
Net Profit Margin---2.108-2.1080%-1.489-29%-0.731-65%-0.339-84%
Operating Margin----0%-0%0.0000%0.043-100%
Operating Ratio--6.6366.6360%3.550+87%3.130+112%2.370+180%
Pb Ratio1.105+13%0.9570.9570%1.013-6%1.779-46%3.101-69%
Pe Ratio-47.104-16%-40.779-40.7790%-17.644-57%15.078-370%47.035-187%
Peg Ratio---26.162-26.1620%-11.863-55%35.723-173%43.505-160%
Price Per Share10.650+13%9.2209.2200%9.040+2%16.002-42%15.491-40%
Price To Total Gains Ratio15.031+13%13.01313.0130%10.381+25%9.450+38%21.840-40%
Profit Growth--1.5591.5590%1.487+5%0.292+434%1.233+26%
Quick Ratio--0.2400.2400%0.235+2%0.572-58%0.613-61%
Return On Assets---0.015-0.0150%-0.037+148%-0.013-13%0.009-262%
Return On Equity---0.023-0.0230%-0.057+145%-0.022-6%0.021-211%
Revenue Growth--0.3120.3120%0.056+460%0.674-54%0.980-68%
Total Gains Per Share--0.7090.7090%0.871-19%1.050-33%0.964-26%
Total Gains Per Share Growth--0.8140.8140%2.520-68%1.042-22%1.658-51%
Usd Book Value--4360706.7004360706.7000%4040058.000+8%4073735.400+7%2719280.658+60%
Usd Book Value Change Per Share--0.0090.0090%0.011-19%0.013-33%0.012-26%
Usd Book Value Per Share--0.1190.1190%0.110+8%0.111+7%0.074+60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.0030%-0.006+127%-0.002-21%0.000-1320%
Usd Free Cash Flow---123897.900-123897.9000%-866608.800+599%-653776.980+428%-326888.490+164%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.024+599%-0.018+428%-0.011+230%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.024+599%-0.009+177%-0.003-25%
Usd Price Per Share0.131+13%0.1130.1130%0.111+2%0.197-42%0.191-40%
Usd Profit---102323.700-102323.7000%-231879.600+127%-80402.640-21%7201.859-1521%
Usd Revenue--48535.80048535.8000%155767.200-69%2076500.760-98%1888523.993-97%
Usd Total Gains Per Share--0.0090.0090%0.011-19%0.013-33%0.012-26%
 EOD+3 -2MRQTTM+0 -0YOY+24 -145Y+19 -1910Y+16 -23

3.2. Fundamental Score

Let's check the fundamental score of VISTA PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-47.104
Price to Book Ratio (EOD)Between0-11.105
Net Profit Margin (MRQ)Greater than0-2.108
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.240
Current Ratio (MRQ)Greater than11.434
Debt to Asset Ratio (MRQ)Less than10.362
Debt to Equity Ratio (MRQ)Less than10.568
Return on Equity (MRQ)Greater than0.15-0.023
Return on Assets (MRQ)Greater than0.05-0.015
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of VISTA PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose10.550
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-03-312019-03-312020-03-312021-03-312022-03-31
Other Current Liabilities  2,494-1,0001,4944,1405,63412,66318,297-18,299-2



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets555,897
Total Liabilities201,368
Total Stockholder Equity354,529
 As reported
Total Liabilities 201,368
Total Stockholder Equity+ 354,529
Total Assets = 555,897

Assets

Total Assets555,897
Total Current Assets153,449
Long-term Assets153,449
Total Current Assets
Cash And Cash Equivalents 109
Net Receivables 25,716
Inventory 93,275
Other Current Assets 1,001
Total Current Assets  (as reported)153,449
Total Current Assets  (calculated)120,101
+/- 33,348
Long-term Assets
Intangible Assets 95,530
Long-term Assets Other 82,175
Long-term Assets  (as reported)402,448
Long-term Assets  (calculated)177,705
+/- 224,743

Liabilities & Shareholders' Equity

Total Current Liabilities106,978
Long-term Liabilities94,390
Total Stockholder Equity354,529
Total Current Liabilities
Short Long Term Debt 31,838
Accounts payable 53,666
Other Current Liabilities -2
Total Current Liabilities  (as reported)106,978
Total Current Liabilities  (calculated)85,502
+/- 21,476
Long-term Liabilities
Long term Debt 93,673
Long-term Liabilities  (as reported)94,390
Long-term Liabilities  (calculated)93,673
+/- 717
Total Stockholder Equity
Total Stockholder Equity (as reported)354,529
Total Stockholder Equity (calculated)0
+/- 354,529
Other
Capital Stock73,588
Common Stock Shares Outstanding 36,794
Net Debt 125,402
Net Invested Capital 480,040
Net Working Capital 46,471



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
144,000
140,600
227,780
263,802
412,500
530,015
527,578
511,217
508,535
555,897
555,897508,535511,217527,578530,015412,500263,802227,780140,600144,000
   > Total Current Assets 
19,000
22,915
119,733
163,420
255,023
278,382
234,469
211,851
152,365
153,449
153,449152,365211,851234,469278,382255,023163,420119,73322,91519,000
       Cash And Cash Equivalents 
2,000
960
970
4,322
57,403
10,290
1,148
1,643
791
109
1097911,6431,14810,29057,4034,3229709602,000
       Net Receivables 
4,000
14,743
115,654
102,205
98,812
132,439
95,272
102,804
21,692
25,716
25,71621,692102,80495,272132,43998,812102,205115,65414,7434,000
       Inventory 
13,000
6,936
2,217
26,760
81,427
109,123
112,459
96,815
96,815
93,275
93,27596,81596,815112,459109,12381,42726,7602,2176,93613,000
   > Long-term Assets 
0
0
0
0
119,353
251,633
293,109
299,366
356,170
402,448
402,448356,170299,366293,109251,633119,3530000
       Property Plant Equipment 
0
116,919
107,282
99,616
117,535
190,409
209,926
198,903
0
0
00198,903209,926190,409117,53599,616107,282116,9190
       Long Term Investments 
0
5
5
5
5
198
293
0
0
0
00029319855550
       Intangible Assets 
0
0
0
0
0
57,365
80,717
95,530
95,530
95,530
95,53095,53095,53080,71757,36500000
       Other Assets 
0
761
761
761
43,660
61,026
82,890
4,762
0
0
004,76282,89061,02643,6607617617610
> Total Liabilities 
58,000
49,653
123,422
151,702
251,097
211,441
169,571
214,797
180,075
201,368
201,368180,075214,797169,571211,441251,097151,702123,42249,65358,000
   > Total Current Liabilities 
56,000
47,027
121,935
72,380
189,313
151,988
109,470
159,218
92,459
106,978
106,97892,459159,218109,470151,988189,31372,380121,93547,02756,000
       Short-term Debt 
0
0
40,372
78,776
53,080
51,803
52,097
0
0
0
00052,09751,80353,08078,77640,37200
       Short Long Term Debt 
0
0
40,372
78,776
53,080
51,803
52,098
99,607
62,837
31,838
31,83862,83799,60752,09851,80353,08078,77640,37200
       Accounts payable 
30,000
43,194
77,470
65,491
129,314
91,276
52,534
51,615
8,404
53,666
53,6668,40451,61552,53491,276129,31465,49177,47043,19430,000
       Other Current Liabilities 
20,000
629
1,176
3,437
3,784
2,494
1,494
5,634
18,297
-2
-218,2975,6341,4942,4943,7843,4371,17662920,000
   > Long-term Liabilities 
0
0
0
0
61,747
59,453
60,101
55,579
87,616
94,390
94,39087,61655,57960,10159,45361,7470000
       Other Liabilities 
0
2,625
1,487
546
522
609
547
514
0
0
005145476095225461,4872,6250
       Deferred Long Term Liability 
0
0
0
0
36,966
57,365
80,717
0
0
0
00080,71757,36536,9660000
> Total Stockholder Equity
0
90,947
104,358
112,100
161,403
318,574
358,007
296,420
328,460
354,529
354,529328,460296,420358,007318,574161,403112,100104,35890,9470
   Common Stock
186,000
150,000
50,000
50,000
53,143
58,294
60,731
60,731
0
0
0060,73160,73158,29453,14350,00050,000150,000186,000
   Retained Earnings 
-109,000
-104,518
8,893
16,635
34,336
56,202
65,596
27,323
-30,638
-4,569
-4,569-30,63827,32365,59656,20234,33616,6358,893-104,518-109,000
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
9,595
9,595
9,595
8,095
63,788
32,919
235,689
0
0
00235,68932,91963,7888,0959,5959,5959,5950



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue3,946
Cost of Revenue-3,973
Gross Profit-27-27
 
Operating Income (+$)
Gross Profit-27
Operating Expense-22,212
Operating Income-18,266-22,239
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,663
Selling And Marketing Expenses-
Operating Expense22,2121,663
 
Net Interest Income (+$)
Interest Income1,657
Interest Expense-8,976
Net Interest Income-7,341-7,319
 
Pretax Income (+$)
Operating Income-18,266
Net Interest Income-7,341
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-25,609-18,266
EBIT - interestExpense = -8,976
-8,319
657
Interest Expense8,976
Earnings Before Interest and Taxes (ebit)--16,633
Earnings Before Interest and Taxes (ebitda)-10,471
 
After tax Income (+$)
Income Before Tax-25,609
Tax Provision--17,290
Net Income From Continuing Ops-8,319-8,319
Net Income-8,319
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-7,341
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ELON.CC
now

I found you a STOCH Bearish Reversal Divergence on the daily chart of ELON.CC.

ELON.CC Daily Candlestick Chart
EFX.CC
2 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of EFX.CC.

EFX.CC Daily Candlestick Chart
EFK.CC
2 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of EFK.CC.

EFK.CC Daily Candlestick Chart
ECOIN.CC
2 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ECOIN.CC.

ECOIN.CC Daily Candlestick Chart
EARN.CC
3 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of EARN.CC.

EARN.CC Daily Candlestick Chart
DYP.CC
3 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of DYP.CC.

DYP.CC Daily Candlestick Chart
DYDX.CC
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DYDX.CC.

DYDX.CC Daily Candlestick Chart
DVI.CC
3 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of DVI.CC.

DVI.CC Daily Candlestick Chart
DVC.CC
3 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of DVC.CC.

DVC.CC Daily Candlestick Chart
DTX.CC
3 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DTX.CC.

DTX.CC Daily Candlestick Chart
DSS.CC
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DSS.CC.

DSS.CC Daily Candlestick Chart
DODO.CC
5 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of DODO.CC.

DODO.CC Daily Candlestick Chart
DKA.CC
6 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of DKA.CC.

DKA.CC Daily Candlestick Chart
DIAMOND.CC
6 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of DIAMOND.CC.

DIAMOND.CC Daily Candlestick Chart
DIA.CC
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DIA.CC.

DIA.CC Daily Candlestick Chart
DGP.CC
6 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of DGP.CC.

DGP.CC Daily Candlestick Chart
DGC.CC
7 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of DGC.CC.

DGC.CC Daily Candlestick Chart
DEV.CC
7 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of DEV.CC.

DEV.CC Daily Candlestick Chart
CZRX.CC
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CZRX.CC.

CZRX.CC Daily Candlestick Chart
IPAXU.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IPAXU.NASDAQ.

IPAXU.NASDAQ Daily Candlestick Chart
CLT.CC
1 hour ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CLT.CC.

CLT.CC Daily Candlestick Chart
CLB.CC
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CLB.CC.

CLB.CC Daily Candlestick Chart
CKB.CC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CKB.CC.

CKB.CC Daily Candlestick Chart
TR.V
1 hour ago

I found you a MACD Bullish Hidden Divergence on the daily chart of TR.V.

TR.V Daily Candlestick Chart
NIFLN0000.CM
1 hour ago

I found you a RSI Bullish Reversal Divergence on the daily chart of NIFLN0000.CM.

NIFLN0000.CM Daily Candlestick Chart